Source:http://linkedlifedata.com/resource/pubmed/id/17167345
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-12-14
|
pubmed:abstractText |
The alpha1/beta2/gamma2-containing heteropentamer is the most abundant gamma-amino-n-butyric acid type A receptor subtype in mammalian brains and the corresponding genes, the GABRA1, GABRB2, and GABRG2 genes, are located in chromosomal region 5q34 that several genome wide scans have implicated as a susceptibility region for schizophrenia. Given this positional and functional evidence, Lo et al. (Mol Psychiatry 2004; 9: 603-608) performed systematic linkage disequilibrium mapping of the GABAAR gene cluster on 5q34 in 130 schizophrenic patients and 170 controls, all of Chinese Han origin. In the single locus and haplotype analyses, single nucleotide polymorphisms in the GABRB2 gene showed highly significant association. The estimated effect caused by GABRB2 varied between odds ratios of 2.27 and 5.12. In order to re-examine their findings, we analyzed the most significantly associated single nucleotide polymorphism in the GABRB2 gene in a sample of 367 patients with schizophrenia and 360 controls, all of German descent. Our sample had a sufficient power to detect the effects described. Neither single marker nor haplotype analysis revealed a significant association with the disease status. Thus, our results do not support the hypothesis that genetic variation at the GABRB2 locus plays a major role in schizophrenic patients of European descent and that such variation would explain the previously observed linkage findings at this chromosomal region.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0955-8829
|
pubmed:author |
pubmed-author:BeckerTimT,
pubmed-author:CichonSvenS,
pubmed-author:DahdouhFatenF,
pubmed-author:DeschnerMonikaM,
pubmed-author:GrossMagdalenaM,
pubmed-author:IlligThomasT,
pubmed-author:JamraRami AbouRA,
pubmed-author:KloppNormanN,
pubmed-author:NöthenMarkus MMM,
pubmed-author:ProppingPeterP,
pubmed-author:RietschelMarcellaM,
pubmed-author:SchmälChristineC,
pubmed-author:SchulzeThomas GTG,
pubmed-author:SchumacherJohannesJ
|
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
43-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17167345-Base Sequence,
pubmed-meshheading:17167345-European Continental Ancestry Group,
pubmed-meshheading:17167345-Genetic Variation,
pubmed-meshheading:17167345-Genotype,
pubmed-meshheading:17167345-Germany,
pubmed-meshheading:17167345-Humans,
pubmed-meshheading:17167345-Polymorphism, Single Nucleotide,
pubmed-meshheading:17167345-Receptors, GABA-A,
pubmed-meshheading:17167345-Schizophrenia
|
pubmed:year |
2007
|
pubmed:articleTitle |
No evidence for an association between variants at the gamma-amino-n-butyric acid type A receptor beta2 locus and schizophrenia.
|
pubmed:affiliation |
Institute of Human Genetics, Department of Psychiatry, Life & Brain Center, University of Bonn, Bonn, Germany. rami.aboujamra@uni-bonn.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|